Last 12 months
Inside the activity.
14 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 8 | 5 |
| Apr 2026 | 2 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 17, 2026 14:13 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 14,000 | $3.16 | $44,240.00 |
DisclosureSEC source: 0000921895-26-002204 · form414528003stim_08172026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,602,988 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.13 tgo $3.17 rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 14:13 UTC |
Chernett Jorey10% owner
|
SaleCall Option (STIM 19FEB27 $5C) · Derivative | 100 | $3.21 Strike: $5.00 | $321.00 |
DisclosureSEC source: 0000921895-26-002204 · form414528003stim_08172026.xml · derivative · entry 2 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2027-02-19 F2 · security: The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. Read SEC document |
| July 23, 2026 Filed Jul 23, 2026 20:15 UTC |
Naor NirEVP, CFO & Treasurer
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001982278-26-000006 · ownership.xml · nonDerivative · entry 1 Naor Nir · CIK 0001982278 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in four equal installments beginning on July 23, 2027, in each case subject to the Reporting Person's continuous employment with the Issuer through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 13:33 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 35,000 | $1.78 | $62,300.00 |
DisclosureSEC source: 0000921895-26-001811 · form414528004_07152026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,588,988 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.79, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:57 UTC |
Amin AvinashDirector
|
OtherCommon Stock | 4,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274343 · ownership.xml · nonDerivative · entry 3 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F4 · shares: Represents shares of common stock transferred to Select Opportunities. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:57 UTC |
Amin AvinashDirector
|
OtherCommon Stock | 34,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274343 · ownership.xml · nonDerivative · entry 2 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,634 F1 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F3 · shares: Represents shares of common stock transferred to Cayman Master. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:57 UTC |
Amin AvinashDirector
|
OtherCommon Stock | 2,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274343 · ownership.xml · nonDerivative · entry 1 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,566 F1 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F2 · shares: Represents shares of common stock transferred to Health Partners. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:47 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
|
OtherCommon Stock | 4,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 6 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,269,073 F8 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F6 · balance_after: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F7 · ownership.nature: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:47 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
|
OtherCommon Stock | 34,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 5 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 17,104,530 F8 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F5 · balance_after: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:47 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
|
OtherCommon Stock | 2,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 4 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,435,958 F8 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F2 · balance_after: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:59 UTC |
Amin AvinashDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002044406-26-000002 · ownership.xml · nonDerivative · entry 1 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,500 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:05 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181190-26-000002 · ownership.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,816 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:02 UTC |
CONLEY SHERYL LDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001238659-26-000002 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,716 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:10 UTC |
Rosengarten MeganDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001876577-26-000003 · ownership.xml · nonDerivative · entry 1 Rosengarten Megan · CIK 0001876577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,890 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:04 UTC |
Cucuz SashaDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002004858-26-000002 · ownership.xml · nonDerivative · entry 1 Cucuz Sasha · CIK 0002004858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,542,798 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:01 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 36,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001218713-26-000002 · ownership.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,017 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed Jun 17, 2026 20:47 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
|
OtherCommon Stock | 3,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,264,439 F1 · kind: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F6 · balance_after: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F7 · ownership.nature: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities. Read SEC document |
| May 28, 2026 Filed Jun 17, 2026 20:47 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
|
OtherCommon Stock | 24,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 17,069,598 F1 · kind: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F5 · balance_after: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| May 28, 2026 Filed Jun 17, 2026 20:47 UTC |
Madryn Asset Management, LP10% owner
Madryn Health Partners II, LP10% owner
MADRYN HEALTH ADVISORS II, LP10% owner
MADRYN HEALTH ADVISORS GP II, LLC10% owner
Madryn Select Opportunities, LP10% owner
|
OtherCommon Stock | 2,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,433,024 F1 · kind: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F2 · balance_after: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| May 19, 2026 Filed May 20, 2026 16:39 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 100,000 | $1.17 | $117,000.00 |
DisclosureSEC source: 0000921895-26-001445 · form414528003stim_05202026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,553,988 Read SEC document |
| May 12, 2026 Filed May 13, 2026 12:31 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 475,000 | $1.34 | $636,500.00 |
DisclosureSEC source: 0000921895-26-001259 · form414528003_05132026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,453,988 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.36, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 13:39 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 100,000 | $1.51 | $151,000.00 |
DisclosureSEC source: 0000921895-26-001056 · form414528003_04222026.xml · nonDerivative · entry 2 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,978,988 F2 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 13:39 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 100,000 | $1.58 | $158,000.00 |
DisclosureSEC source: 0000921895-26-001056 · form414528003_04222026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,878,988 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.59, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 30, 2026 Filed Mar 30, 2026 23:41 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 385,442 | $1.25 | $481,802.50 |
DisclosureSEC source: 0000921895-26-000835 · form414528003_03302026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,778,988 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.26, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. F2 · balance_after: This amount corrects a clerical error in the Reporting Person's Form 4 previously filed on March 30, 2026, in which the number of shares beneficially owned by the Reporting Person was under-reported by 270 shares. Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 13:37 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 500,000 | $1.35 | $675,000.00 |
DisclosureSEC source: 0000921895-26-000822 · form414528003stim_03302026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,393,276 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.41, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 13:33 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 25,000 | $1.44 | $36,000.00 |
DisclosureSEC source: 0000921895-26-000813 · form414528003stim_03272026.xml · nonDerivative · entry 2 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,893,276 Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 13:33 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 125,000 | $1.40 | $175,000.00 |
DisclosureSEC source: 0000921895-26-000813 · form414528003stim_03272026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,868,276 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 23, 2026 Filed Mar 23, 2026 20:41 UTC |
REUVERS DANIEL L.President and CEO
|
GrantCommon Stock | 1,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001563602-26-000006 · ownership.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500,000 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 13:34 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 169,472 | $1.41 | $238,955.52 |
DisclosureSEC source: 0001193805-26-000308 · e665271_4-stim.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,743,276 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.44, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 12:51 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 450,000 | $1.33 | $598,500.00 |
DisclosureSEC source: 0000921895-26-000751 · form414528003sti_03202026.xml · nonDerivative · entry 2 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,573,804 F2 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.48, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 19, 2026 Filed Mar 24, 2026 21:50 UTC |
Sullivan Keith JFormer Officer & Director
|
SaleCommon Stock | 46,289 | $1.34 | $62,027.26 |
DisclosureSEC source: 0001193125-26-122295 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Former Officer & Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,590,924 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2026 Filed Mar 24, 2026 21:52 UTC |
Pfanstiel StevenEVP, CFO and Treasurer
|
SaleCommon Stock | 16,431 | $1.34 | $22,017.54 |
DisclosureSEC source: 0001193125-26-122298 · ownership.xml · nonDerivative · entry 1 Pfanstiel Steven · CIK 0001856059 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,781 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2026 Filed Mar 24, 2026 21:48 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
SaleCommon Stock | 16,005 | $1.34 | $21,446.70 |
DisclosureSEC source: 0001193125-26-122290 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 897,270 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2026 Filed May 21, 2026 20:05 UTC Amendment |
Pfanstiel StevenFormer EVP, CFO and Treasurer
|
SaleCommon Stock | 8,569 | $1.34 | $11,482.46 |
DisclosureSEC source: 0001856059-26-000002 · ownership.xml · nonDerivative · entry 1 Pfanstiel Steven · CIK 0001856059 · Former EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 836,643 F1 · shares: The Form 4 filed on March 24, 2026 inadvertently reported the disposition of 16,431 shares of common stock in connection with non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. However, the correct amount is 8,569 shares of common stock. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 12:51 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 607,400 | $1.35 | $819,990.00 |
DisclosureSEC source: 0000921895-26-000751 · form414528003sti_03202026.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,123,804 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.37, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 14:36 UTC |
Chernett Jorey10% owner
|
PurchaseCommon Stock | 531,000 | $1.16 | $615,960.00 |
DisclosureSEC source: 0001193805-26-000282 · e665257_4-neuronetics.xml · nonDerivative · entry 1 Chernett Jorey · CIK 0002042077 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,516,404 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.91 to $1.31, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 20:34 UTC |
Sullivan Keith JDirector · President and CEO
|
GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-114117 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,637,213 F1 · price: Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 20:33 UTC |
Pfanstiel StevenEVP, CFO and Treasurer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-114111 · ownership.xml · nonDerivative · entry 1 Pfanstiel Steven · CIK 0001856059 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,212 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 17, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 20:34 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
GrantCommon Stock | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-114114 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 913,275 F1 · price: Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:29 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
SaleCommon Stock | 609 | $1.34 | $816.06 |
DisclosureSEC source: 0001193125-26-096629 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 879,525 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.39 to $1.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:33 UTC |
Sullivan Keith JDirector · President and CEO
|
SaleCommon Stock | 8,452 | $1.35 | $11,410.20 |
DisclosureSEC source: 0001193125-26-082872 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,524,713 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:34 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
SaleCommon Stock | 3,427 | $1.35 | $4,626.45 |
DisclosureSEC source: 0001193125-26-082878 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880,134 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:30 UTC |
Pfanstiel StevenEVP, CFO and Treasurer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-071774 · ownership.xml · nonDerivative · entry 1 Pfanstiel Steven · CIK 0001856059 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 820,212 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:30 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
GrantCommon Stock | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-071773 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,561 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 22:44 UTC |
Sullivan Keith JDirector · President and CEO
|
SaleCommon Stock | 33,847 | $1.65 | $55,847.55 |
DisclosureSEC source: 0001193125-26-057541 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,533,165 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 22:42 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
SaleCommon Stock | 14,120 | $1.65 | $23,298.00 |
DisclosureSEC source: 0001193125-26-057538 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,561 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:31 UTC |
Sullivan Keith JDirector · President and CEO
|
SaleCommon Stock | 40,976 | $1.55 | $63,512.80 |
DisclosureSEC source: 0001193125-26-048847 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,567,012 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.45 to $1.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:32 UTC |
MACAN WILLIAM ANDREWEVP, CLO and CS
|
SaleCommon Stock | 3,485 | $1.55 | $5,401.75 |
DisclosureSEC source: 0001193125-26-048851 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 687,681 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.45 to $1.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 22:05 UTC |
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
|
GrantCommon Stock | 164,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-338393 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 691,166 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (i) June 30, 2027 and (ii) the termination of Mr. Macan's employment from the Issuer without cause. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 22:05 UTC |
Pfanstiel StevenEVP, CFO and Treasurer
|
GrantCommon Stock | 170,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-338392 · ownership.xml · nonDerivative · entry 1 Pfanstiel Steven · CIK 0001856059 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,212 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (i) June 30, 2027 and (ii) the termination of Mr. Pfanstiel's employment from the Issuer without cause. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.